Phenotypic and transcriptomic characterization of canine myeloid-derived suppressor cells-Reference-Cited by-同舟云学术

Phenotypic and transcriptomic characterization of canine myeloid-derived suppressor cells

Published:2019-03-05 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Goulart Michelle R.,Hlavaty Sabina I.,Chang Yu-Mei,Polton Gerry^ORCID,Stell Anneliese,Perry James,Wu Ying,Sharma Eshita^ORCID,Broxholme John,Lee Avery C.,Szladovits Balazs,Turmaine Mark,Gribben John,Xia Dong,Garden Oliver A.^ORCID

Funder

Wellcome Trust

Petplan Charitable Trust

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-40285-3.pdf

Reference93 articles.

1. Pyzer, A. R., Cole, L., Rosenblatt, J. & Avigan, D. E. Myeloid-derived suppressor cells as effectors of immune suppression in cancer. Int J Cancer 139, 1915–1926, https://doi.org/10.1002/ijc.30232 (2016).

2. Treffers, L. W., Hiemstra, I. H., Kujpers, T. W., van den Berg, T. K. & Matlung, H. L. Neutrophils in cancer. Immunol Rev 273, 312–328 (2016).

3. Kumar, V., Patel, S., Tcyganov, E. & Gabrilovich, D. I. The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends Immunol 37, 208–220, https://doi.org/10.1016/j.it.2016.01.004 (2016).

4. Bronte, V. et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun 7, 12150, https://doi.org/10.1038/ncomms12150 (2016).

5. Diaz-Montero, C. M., Finke, J. & Montero, A. J. Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications. Semin Oncol 41, 174–184, https://doi.org/10.1053/j.seminoncol.2014.02.003 (2014).

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application;Frontiers in Immunology;2024-05-02

2. Myeloid derived suppressor cells in peripheral blood can be a prognostic factor in canine transitional cell carcinoma;Veterinary Immunology and Immunopathology;2024-03

3. Canine cancer immunology and immunotherapy;The Immunology of the Dog;2024

4. NLRP3/IL‐1β induced myeloid‐derived suppressor cells recruitment and PD‐L1 upregulation promotes oxaliplatin resistance of hepatocellular carcinoma;MedComm;2023-12

5. Cancer Immunotherapy;Therapeutic Strategies in Veterinary Oncology;2023-08-23